Biomaterial Database

Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients. 1989

E Singlas, and J C Pioger, and A M Taburet, and S Colaneri, and J P Fillastre

Pharmacie Clinique, Hôpital Bicêtre, Rouen, France.

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D006679	HIV Seropositivity	Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).	AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D015215	Zidovudine	A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.	AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

E Singlas, and J C Pioger, and A M Taburet, and S Colaneri, and J P Fillastre

Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.

September 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,

E Singlas, and J C Pioger, and A M Taburet, and S Colaneri, and J P Fillastre

Erratic zidovudine bioavailability in HIV seropositive patients.

March 1993, The Journal of antimicrobial chemotherapy,

E Singlas, and J C Pioger, and A M Taburet, and S Colaneri, and J P Fillastre

Pharmacokinetics of trantinterol and its metabolite in healthy elderly and young subjects.

October 2015, International journal of clinical pharmacology and therapeutics,

E Singlas, and J C Pioger, and A M Taburet, and S Colaneri, and J P Fillastre

Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.

November 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,

E Singlas, and J C Pioger, and A M Taburet, and S Colaneri, and J P Fillastre

Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects.

July 2003, Acta pharmacologica Sinica,